Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 465 | -157 | 309,060 | 92 | -215 |
| Depreciation Amortization | 148 | 80 | 362 | 279 | 192 |
| Accounts receivable | -41 | 598 | -977 | -335 | 198 |
| Other Working Capital | -1,158 | -190 | -634 | 421 | 773 |
| Other Operating Activity | 155 | -523 | -307,560 | 492 | -100 |
| Operating Cash Flow | $-432 | $-192 | $252 | $948 | $848 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144 | -73 | -377 | -296 | -221 |
| Investing Cash Flow | $-144 | $-73 | $-377 | $-296 | $-221 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 5 | 29 | 29 |
| Debt Repayment | 234 | -8 | -24 | -16 | -9 |
| Common Stock Issued | 21 | 2 | N/A | N/A | N/A |
| Financing Cash Flow | $255 | $-5 | $-19 | $13 | $20 |
| Beginning Cash Position | 1,068 | 1,068 | 1,212 | 1,212 | 1,212 |
| End Cash Position | 747 | 798 | 1,068 | 1,877 | 1,859 |
| Net Cash Flow | $-321 | $-270 | $-144 | $665 | $647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -432 | -192 | 252 | 948 | 848 |
| Capital Expenditure | -144 | -73 | -391 | -310 | -235 |
| Free Cash Flow | -576 | -265 | -139 | 638 | 613 |